ZYBERNO
Stock Report
Updated Jun 7, 2026

Abpro Holdings, Inc. (ABP)

Healthcare • NASDAQ

$0.12

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
13.0/100
POOR BUSINESS
Abpro Holdings, Inc. (ABP) scores 13/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-328.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Abpro Holdings, Inc. (ABP) stock report — Zyberno Score 13/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.12
Market Cap:$547.84K

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$4.25M
B. Profitability Assessment

Return Metrics (4)

ROA:-210.6%
Reinvestment Rate:1.5%
Fundamental Growth Rate (g):-5.0%

Margin Analysis (1)

Ebitda Margin:-3,506.0%

Yield Metrics (2)

Earnings Yield:-$1.19K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):100.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.74x
Quick Ratio:0.74x
Cash Ratio:0.59x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-23.96x
Times Interest Earned:-23.96

Capital Structure (4)

Working Capital:-2,416,000.00
Cash And Cash Equivalents:5,398,000.00
Long Term Debt:$456.00K
Net Debt:-$4.79M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$183.00K
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$6.43M

Bottom Line Performance (3)

Net income TTM: -$6.90M
Linear Growth: 100.0%
📊 Click to view full ABP Net Income analysis & methodology →
Income Before Tax:-$7.23M
Ebitda Ttm:-6,416,000.00

Operating Expenses (5)

Operating Expenses:6,427,000.00
R And D Expense:677,000.00
Sga Expense:5,750,000.00
Income Tax Expense:$141.78K
Interest Expense:414,000.00

Expense Ratios (3)

R And D To Revenue Percentage:369.9%
Sga To Revenue Percentage:3,142.1%
Ebitda Margin:-3,506.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$6.87M
Current Assets:$6.70M
Ppe Net:2,682,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:9,117,000.00
Current Liabilities:9,117,000.00
Long Term Debt:$456.00K
Short Term Debt:$149.00K

Equity & Capital (3)

Equity:-$2.25M
Retained Earnings:-$120.02M
Common Stock:110,000,000.00

Working Capital Items (3)

Accounts Receivable:183,000.00
Inventory:0.00
Accounts Payable:4,952,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:302,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$6.37M$0.00

Investment Activities (1)

Investing Cash Flow:$29.69M

Financing Activities (3)

Financing Cash Flow:$7.41M
Dividends Paid Ttm:0.00
Stock Repurchase:29,728,990.00

Capital Transactions (3)

Common Stock Issuance:132,000.00
Long Term Debt Issuance:$1.84M
Long Term Debt Repayments:$206.00K

Non-Cash Items (1)

Depreciation Amortization Ttm:11,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.45
-$1.45
Earnings Per Share Ttm:-$1.54

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.04
Operating Cash Flow Per Share:-$2.01

Book Value & Capital (2)

Book Value Per Share:-$0.50
Cash Per Share:1.20

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.06x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:1.00x
Days Sales Outstanding Ttm:365.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:9,876.94
Cash Conversion Cycle:-10,510.94
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:1.5%
Fundamental Growth Rate (g):-5.0%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Net Income Growth Rate (Linear):100.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:ABP
Company Name:Abpro Holdings, Inc.
Sector:Healthcare
Industry:Biological Products, (No Diagnostic Substances)
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:4.49M
Shares Outstanding Basic:4.49M
Shares Outstanding Diluted:4.49M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-06-07 16:36:12 UTC
Data Timestamp:2026-06-07T16:36:12.414263
Scroll to Top